Etid klinik pou VIH nan Maryland
29 etid pou VIH ap chèche patisipan nan sit nan Maryland.
Vil nan Maryland
Tèks ofisyèl etid la (Anglè)
Implementation Study of Lenacapavir Pre-exposure Prophylaxis for HIV Prevention
- Chase Brexton Health Care, Baltimore
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT07473778A Study to Investigate Cabotegravir Ultra Long-Acting (CAB ULA) Plus Rilpivirine Ultra Long-Acting (RPV ULA) in Adults and Adolescents With HIV Who Are Virologically Suppressed
- GSK Investigational Site, Baltimore
Ap rekriteFaz 3
Laj 12 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07650916Specimen Collections From Participants With HIV Infection, KSHV Infection, Viral-Related Pre-malignant Lesions and Cancer
- National Institutes of Health Clinical Center, Bethesda
Ap rekriteEtid obsèvasyon
Laj 18 a 120 · Tout sèks · Mizajou Sep 28, 2026 · NCT00006518Leukapheresis Procedures to Obtain Plasma and Lymphocytes for Research Studies on Antiretroviral Naive HIV-1 Research Participants
- National Institutes of Health Clinical Center, Bethesda
Ap rekriteEtid obsèvasyon
Laj 18 a 120 · Tout sèks · Mizajou Sep 28, 2026 · NCT00039689Viral Load in Blood and Lymph Tissues in People Living With HIV
- National Institutes of Health Clinical Center, Bethesda
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 a 100 · Tout sèks · Mizajou Sep 28, 2026 · NCT00001316Molecular Characterization of Viral-associated Tumors, Tumors Occurring in the Setting of HIV or Other Immune Disorders and Castleman Disease
- National Institutes of Health Clinical Center, Bethesda
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT03300830Leukapheresis to Obtain Plasma or Lymphocytes for Studies of HIV-infected Patients, Including Long-term Non-progressors
- National Institutes of Health Clinical Center, Bethesda
Ap rekriteEtid obsèvasyon
Laj 18 a 100 · Tout sèks · Mizajou Sep 22, 2026 · NCT00029445Imaging and Biopsy of People With HIV-1 Undergoing Analytic Treatment Interruption
- National Institutes of Health Clinical Center, Bethesda
Ap rekriteFaz 2
Laj 18 a 100 · Tout sèks · Mizajou Sep 22, 2026 · NCT05419024Trial of Allogeneic Reduced-Intensity, HLA-Haploidentical Allogeneic Hematopoietic Cell Bone Marrow Transplantation Followed by Graft-versus-Host-Disease (GVHD) Prophylaxis With Cyclophosphamide, Bortezomib and Maraviroc for Hematologic Malignancies ...
- National Institutes of Health Clinical Center, Bethesda
Ap rekriteFaz 1/2Volontè an sante akeyi
Laj 12 a 120 · Tout sèks · Mizajou Sep 22, 2026 · NCT05470491Pomalidomide and Nivolumab in People With Virus-Associated Malignancies With or Without HIV
- National Institutes of Health Clinical Center, Bethesda
Ap rekriteFaz 1
Laj 18 a 99 · Tout sèks · Mizajou Sep 17, 2026 · NCT04902443Very Early Intensive Treatment of Infants Living With HIV to Achieve HIV Remission
- 5092, Johns Hopkins Clinical Research Site, Baltimore
Ap rekriteFaz 1/2
48 Hours · Tout sèks · Mizajou Sep 9, 2026 · NCT02140255Natural History Study of Progressive Multifocal Leukoencephalopathy (PML)
- National Institutes of Health Clinical Center, Bethesda
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 2 a 120 · Tout sèks · Mizajou Aug 31, 2026 · NCT01730131Clinical and Immunologic Monitoring of Patients With Known or Suspected HIV Infection
- National Institutes of Health Clinical Center, Bethesda
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Aug 27, 2026 · NCT00789009Abemaciclib in Patients With HIV-associated and HIV-negative Kaposi Sarcoma
- National Institutes of Health Clinical Center, Bethesda
Ap rekriteFaz 1/2
Laj 18 a 99 · Tout sèks · Mizajou Aug 25, 2026 · NCT04941274PDS01ADC Monotherapy and in Combination With M7824 in Advanced Kaposi Sarcoma
- National Institutes of Health Clinical Center, Bethesda
Ap rekriteFaz 1/2
Laj 18 a 99 · Tout sèks · Mizajou Aug 24, 2026 · NCT04303117Expanding HOPE Liver
- Johns Hopkins University (Site #: 71119), Baltimore
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Aug 21, 2026 · NCT07778459Screen2Prevent (S2P)
- Johns Hopkins University, Baltimore
Ap rekriteVolontè an sante akeyi
Laj 14 a 24 · Tout sèks · Mizajou Aug 17, 2026 · NCT07728123A Study to Evaluate the Use of Resmetirom in Participants With MASLD and HIV
- Johns Hopkins University, Baltimore
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Jul 30, 2026 · NCT07143968A Study to Investigate the Safety and PK of VH4770359 in Healthy Participants
- GSK Investigational Site, Baltimore
Ap rekriteFaz 1Volontè an sante akeyi
Laj 18 a 55 · Tout sèks · Mizajou Jul 13, 2026 · NCT07525544Lenacapavir Intensification to Disrupt HIV Reservoirs in Virologically Suppressed People With HIV Receiving Antiretroviral Therapy
- National Institutes of Health Clinical Center, Bethesda
Ap rekriteFaz 1
Laj 18 a 75 · Tout sèks · Mizajou Jul 8, 2026 · NCT06819176Kidney Transplantation From Donors With HIV: Impact on Rejection and Long-Term Outcomes (Expanding HOPE Kidney)
- Johns Hopkins University, Baltimore
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Jun 22, 2026 · NCT06263426Skeletal Muscle Energetics and Fatiguability in Older Individuals
- Johns Hopkins Hospital, Baltimore
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 60 a 90 · Tout sèks · Mizajou Jun 8, 2026 · NCT04142047Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Jun 1, 2026 · NCT05663502Menopausal HT for Women Living With HIV (HoT)
- 201 Johns Hopkins University CRS, Baltimore
Ap rekriteFaz 4
Laj 40 a 60 · Fanm · Mizajou May 22, 2026 · NCT06856174A Setting Focus Overdose Prevention Intervention
- Lighthouse Studies at Peer Point, Baltimore
Ap rekriteVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou May 22, 2026 · NCT05320835The Collaborative Care PrTNER Study
- Johns Hopkins Center for Adolescent and Young Adult Health, Baltimore
Ap rekriteVolontè an sante akeyi
Laj 15 a 29 · Gason · Mizajou May 18, 2026 · NCT06585631Strategies to AchieVe Viral Suppression for Youth With HIV
- Johns Hopkins University, Baltimore
Ap rekrite
Laj 12 a 30 · Tout sèks · Mizajou Feb 4, 2026 · NCT06886971Syringe Service Based Telemedicine and Social Network Driven HIV Prevention Service Implementation
- Johns Hopkins Hospital, Baltimore
- Frederick County Health Department, Street Safe Program, Frederick
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Nov 10, 2025 · NCT06103370Peer Behavioral Activation Utilization to Improve Substance Use and HIV Outcomes in People Receiving Long Acting Injectable-PrEP/ART (PUSH)
- Baltimore Safe Haven, Baltimore
Ap rekriteVolontè an sante akeyi
Laj 18 a 88 · Tout sèks · Mizajou Oct 31, 2025 · NCT06501781Sous ClinicalTrials.gov, done yo ranmase Oct 2, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.